Washington- As per media reports, the Food and Drug Administration (FDA) is soon likely to authorize the administration of the Pzifer COVID-19 vaccines for adolescents aged between 12-15 from as early as next week.
Keeping in mind the alarming surge in the COVID-19 cases in the United States making it the worst COVID-19 affected nation in the world, the government has put forth the decision to make adolescents between the age 12-15 eligible for the vaccine as the new strains of the novel coronavirus, unlike during the first wave of the pandemic, is seen to have the potential to even infect children.
The Pzifer has applied for emergency use authorization for the COVID-19 vaccine for children and teenagers between the ages 12-15, as per a government official.
"The FDA will have to amend the emergency use authorization for the vaccine, but the process should be straightforward," cited CNN.
The FDA is expected to notify the public of its decision by next week, after which the Centers for Disease Control and Prevention advisory committee will hold a meeting to discuss how the vaccination will be used. "We are working to review this request as quickly and transparently as possible," a spokesperson of the FDA said.
The current age requirement for the Pzifer vaccine is 16 and the Moderna and Johnson & Johnson is 18. Trials are ongoing by the vaccine companies for the administration of the COVID-19 vaccines among the younger age groups like children and early teenagers.
As per a recent trial conducted by Pfizer-BioNTech, the two-dose vaccine was extremely safe and effective among the 2,260 adolescents aged between 12-15. In the same trial, 16 COVID-19 infected adolescents received the placebo and not the real vaccine.
COVID-19 vaccine company Moderna is conducting trials of its vaccine for teens and younger children, the results for which will soon be in the public domain by summer. Johnson & Johnson is also conducting similar trials on teens and adolescents.
The US set a goal to vaccinate the entire population by the 4th of July and have steadily ramped up the production of COVID-19 vaccines, mainly Pfizer and Moderna.